These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 18825527)
21. Synthesis, biological evaluation and molecular modeling of substituted 2-aminobenzimidazoles as novel inhibitors of acetylcholinesterase and butyrylcholinesterase. Zhu J; Wu CF; Li X; Wu GS; Xie S; Hu QN; Deng Z; Zhu MX; Luo HR; Hong X Bioorg Med Chem; 2013 Jul; 21(14):4218-24. PubMed ID: 23719283 [TBL] [Abstract][Full Text] [Related]
22. Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment. Czarnecka K; Chufarova N; Halczuk K; Maciejewska K; Girek M; Skibiński R; Jończyk J; Bajda M; Kabziński J; Majsterek I; Szymański P Eur J Med Chem; 2018 Feb; 145():760-769. PubMed ID: 29353726 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular docking of new acridine-coumarin hybrids. Hamulakova S; Janovec L; Soukup O; Jun D; Kuca K Int J Biol Macromol; 2017 Nov; 104(Pt A):333-338. PubMed ID: 28601645 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Huang L; Shi A; He F; Li X Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426 [TBL] [Abstract][Full Text] [Related]
26. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation. Rouleau J; Iorga BI; Guillou C Eur J Med Chem; 2011 Jun; 46(6):2193-205. PubMed ID: 21435752 [TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationship investigation of benzamide and picolinamide derivatives containing dimethylamine side chain as acetylcholinesterase inhibitors. Gao XH; Liu LB; Liu HR; Tang JJ; Kang L; Wu H; Cui P; Yan J J Enzyme Inhib Med Chem; 2018 Dec; 33(1):110-114. PubMed ID: 29166796 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors. Skrzypek A; Matysiak J; Niewiadomy A; Bajda M; Szymański P Eur J Med Chem; 2013 Apr; 62():311-9. PubMed ID: 23376249 [TBL] [Abstract][Full Text] [Related]
29. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors. Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives. Wu ZP; Wu XW; Shen T; Li YP; Cheng X; Gu LQ; Huang ZS; An LK Arch Pharm (Weinheim); 2012 Mar; 345(3):175-84. PubMed ID: 21989769 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives. Liu H; Fan H; Gao X; Huang X; Liu X; Liu L; Zhou C; Tang J; Wang Q; Liu W J Enzyme Inhib Med Chem; 2016 Aug; 31(4):580-9. PubMed ID: 26186269 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches. Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746 [TBL] [Abstract][Full Text] [Related]
33. Structure-toxicity relationships of thiono and seleno phosphoramidate compounds: new type of acetylcholinesterase inhibitors. Dehghanpour S; Rasmi Y; Bagheri M Mol Divers; 2007 Feb; 11(1):47-57. PubMed ID: 17406998 [TBL] [Abstract][Full Text] [Related]
34. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase. Petzer A; Harvey BH; Petzer JP Toxicol Appl Pharmacol; 2014 Feb; 274(3):488-93. PubMed ID: 24161345 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase. Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709 [TBL] [Abstract][Full Text] [Related]
36. Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling. Feng B; Li X; Xia J; Wu S J Enzyme Inhib Med Chem; 2017 Dec; 32(1):968-977. PubMed ID: 28718678 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors. Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231 [TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of huperzine B on cholinesterase activity in mice. Liu J; Zhang HY; Wang LM; Tang XC Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):141-5. PubMed ID: 10437161 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors. Qiu GL; He SS; Chen SC; Li B; Wu HH; Zhang J; Tang WJ J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1506-1515. PubMed ID: 30284486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]